| 1. |
Ruemmele P, Hofstaedter F, Gelbmann CM. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2009; 6:287-95.
|
| 2. |
Abdalian R, Heathcote EJ. Sclerosing gholangitis: a focus on secondary causes. Hepatology 2006; 44:1063-74.
|
| 3. |
Xia J, Ren Z, Ye S, et al. Study of severe and rare com-plications of transarterial chemoembolization (TACE) for liver cancer. Eur J Radiol 2006; 59:407-12.
|
| 4. |
Sakamoto I, Iwanaga S, Nagaoki K, et al. Intrahepatic biloma formation (bile duct necrosis) after transcatheter arterial chemoembolization. Am J Roentgenol 2003; 181: 79-87.
|
| 5. |
Richardet JP, Lons T, Sibony M, et al. Secondary sclerosing cholangitis and chemoembolization with lipiodol. Gas-troenterol Clin Biol 1994; 18:168-71.
|
| 6. |
Kobayashi S, Nakanuma Y, Terada T, et al. Postmortem survey of bile duct necrosis and biloma in hepatocellular carcinoma after transcatheter arterial chemoembolization therapy: relevance to microvascular damages of peribil-iary capillary plexus. Am J Gastroenterol 1993; 88:1410- 5.
|
| 7. |
Deltenre P, Valla DC. Ischemic cholangiopathy. J Hepatol 2006; 44:806-17.
|
| 8. |
Kemeny MM, Battifora H, Blayney DW, et al. Sclerosing cholangitis after continuous hepatic artery infusion of FUDR. Ann Surg 1985; 202:176-81.
|
| 9. |
Chung JW, Park JH, Han JK, et al. Hepatic tumors: Pre-disposing factors for complications of transcatheter oily chemoembolization. Radiology 1996; 198:33-40.
|
| 10 |
Yu JS, Kim KW, Jeong MG, et al. Predisposing factors of bile duct injury after transcatheter arterial chemoem-bolization (TACE) for hepatic malignancy. Cardiovasc Intervent Radiol 2002; 25:270-4.
|
| 11 |
Alazmi WM, McHenry L, Watkins JL, et al. Chemother-apy-induced sclerosing cholangitis: long-term response to endoscopic therapy. J Clin Gastroenterol 2006; 40:353-7.
|
| 12 |
Lindor KD, Kowdley KV, Luketic VA, et al. High-dose ur-sodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology 2009; 50:808-14.
|
